Skip to main content
. 2020 Nov 20;4(22):5762–5771. doi: 10.1182/bloodadvances.2020002814

Table 3.

Risk scores in each potential risk group and categorization

Indicator variables Calculated risk score Risk groups by tertiles No. of patients designated
sIPI B symptoms Pretransplant DS PM SMC
Low Absence 1-3 0.000 Low 34 15
Low Presence 1-3 0.658 Low 3 1
Low-intermediate Absence 1-3 0.951 Low 19 7
Low Absence 4 1.087 Low 21 7
High-intermediate or high Absence 1-3 1.312 Low 15 7
Low-intermediate Presence 1-3 1.609 Intermediate 5 5
Low Presence 4 1.745 Intermediate 4 0
High-intermediate or high Presence 1-3 1.970 Intermediate 10 1
Low-intermediate Absence 4 2.039 Intermediate 17 2
High-intermediate or high Absence 4 2.400 Intermediate 12 3
Low Absence 5 2.611 High 4 2
Low-intermediate Presence 4 2.696 High 3 2
High-intermediate or high Presence 4 3.057 High 11 2
Low-intermediate Absence 5 3.562 High 4 3
High-intermediate or high Absence 5 3.923 High 4 1
High-intermediate or high Presence 5 4.581 High 0 2

A linear predictor was calculated using the weighted sums of the indicator variables and their β coefficients and was categorized into tertiles.